Form 4: Celularity Inc. Executive Stephen Brigido Reports Stock Transactions

Stephen Brigido, Pres. of Functional Regeneration at Celularity Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On April 13, 2025, Stephen Brigido, Pres. of Functional Regeneration at Celularity Inc., reported transactions involving Class A Common Stock.
• Brigido converted 820 restricted stock units (RSUs) into Class A Common Stock upon vesting.
• This represents 25% of the 3,281 RSUs granted on April 13, 2022, which vested on April 13, 2025.
• Additionally, 268 shares were disposed of to cover tax withholding obligations related to the RSU vesting at a price of $1.64.
• Following these transactions, Brigido directly owns 8,921 shares of Class A Common Stock and 820 Restricted Stock Units.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they represent a small portion of the overall outstanding shares.

Key Dates

Keywords

Form 4, Celularity Inc, Stephen Brigido, Restricted Stock Units, Class A Common Stock, Vesting, Tax Withholding, Insider Trading